1. Ruiz-Fernández de Córdoba, Borja, Martínez-Monge, Rafael, Lecanda, Fernando. . ENPP1 Immunobiology as a Therapeutic Target. In Clinical cancer research : an official journal of the American Association for Cancer Research, 29, 2184-2193. doi:10.1158/1078-0432.CCR-22-1681. https://pubmed.ncbi.nlm.nih.gov/36719675/
2. Gu, Xiao-Jing, Su, Wei-Ming, Dou, Meng, Li, Guo-Bo, Chen, Yong-Ping. 2023. Expanding causal genes for Parkinson's disease via multi-omics analysis. In NPJ Parkinson's disease, 9, 146. doi:10.1038/s41531-023-00591-0. https://pubmed.ncbi.nlm.nih.gov/37865667/
3. Chen, Min, Meng, Yingdi, Shi, Xiaoqiong, Tang, Haihong, Zheng, Hongliang. 2024. Identification of ENTPD1 as a novel biomarker linking allergic rhinitis and systemic lupus erythematosus. In Scientific reports, 14, 18266. doi:10.1038/s41598-024-69228-3. https://pubmed.ncbi.nlm.nih.gov/39107483/
4. Mamelona, Jean, Crapoulet, Nicolas, Marrero, Alier. 2019. A new case of spastic paraplegia type 64 due to a missense mutation in the ENTPD1 gene. In Human genome variation, 6, 5. doi:10.1038/s41439-018-0036-4. https://pubmed.ncbi.nlm.nih.gov/30652007/
5. Calame, Daniel G, Herman, Isabella, Maroofian, Reza, Marafi, Dana, Lupski, James R. 2022. Biallelic Variants in the Ectonucleotidase ENTPD1 Cause a Complex Neurodevelopmental Disorder with Intellectual Disability, Distinct White Matter Abnormalities, and Spastic Paraplegia. In Annals of neurology, 92, 304-321. doi:10.1002/ana.26381. https://pubmed.ncbi.nlm.nih.gov/35471564/
智鼠故事 
